Solid Biosciences (SLDB) Consolidated Net Income (2017 - 2024)
Historic Consolidated Net Income for Solid Biosciences (SLDB) over the last 7 years, with Q4 2024 value amounting to -$38.0 million.
- Solid Biosciences' Consolidated Net Income fell 8463.55% to -$38.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$120.6 million, marking a year-over-year decrease of 2418.8%. This contributed to the annual value of -$120.6 million for FY2024, which is 2418.8% down from last year.
- Latest data reveals that Solid Biosciences reported Consolidated Net Income of -$38.0 million as of Q4 2024, which was down 8463.55% from -$32.9 million recorded in Q3 2024.
- In the past 5 years, Solid Biosciences' Consolidated Net Income registered a high of -$19.0 million during Q2 2020, and its lowest value of -$38.0 million during Q4 2024.
- Over the past 4 years, Solid Biosciences' median Consolidated Net Income value was -$24.9 million (recorded in 2023), while the average stood at -$25.6 million.
- Its Consolidated Net Income has fluctuated over the past 5 years, first soared by 3761.81% in 2023, then tumbled by 8463.55% in 2024.
- Solid Biosciences' Consolidated Net Income (Quarter) stood at -$21.4 million in 2020, then plummeted by 54.62% to -$33.0 million in 2022, then soared by 37.62% to -$20.6 million in 2023, then crashed by 84.64% to -$38.0 million in 2024.
- Its Consolidated Net Income stands at -$38.0 million for Q4 2024, versus -$32.9 million for Q3 2024 and -$25.3 million for Q2 2024.